The email you have inserted is not registered at Medicon Valley Online. If you wish to gain access to a specific organization profile please speak to one of the registered contacts of that organization. The registered contacts can usually be found on the profile page of that organization.
The email you have inserted is not in our database. Plese try again!
To add a compound to a pipeline your organisation needs to be registered as a biotech or pharmaceutical company at Medicon Valley Online. If your organisation is already registered please click on the Sign in button below. If you wish to register a new organisation, please click the Register button.
To add a service your organisation needs to be registered at Medicon Valley Online as a member of Medicon Valley Alliance and have paid the one time fee of 2300 EUR for the service section. If this has been accomplished please, just click the Sign in button below. If you want access to the services section or media about it please send your contact details to contact@mediconvalleyonline.com and we will get back to you.
Please enter your email address in the field below. Once submitted a message, with an authorization link, will be sent to this address so that you can set a new password for your account. You will have access to you account again in a couple of minutes. Thank you for your patience.
Drug compounds in clinical development by Biotech and Pharmaceutical companies located in Medicon Valley. Listed compounds must have their clinical development managed or administered from a site within Medicon Valley.
Compound
Company
Primary Therapeutical Area / Indication
Drug development
Egalet® Oxycodone PR
Nervous System Diseases / Complex Regional Pain Syndromes
Phase I
Lu 02-750
Nervous System Diseases / Parkinson Disease
Phase I
Lu AE04621
Nervous System Diseases / Parkinson Disease
Phase I
Lu AF11167
Nervous System Diseases
Phase I
Neublastin
Nervous System Diseases / Neuropathic pain
Phase I
NsG0202
Nervous System Diseases / Alzheimer Disease
Phase I
Ordopidine
Nervous System Diseases / Parkinson Disease
Phase I
Seridopidine
Nervous System Diseases / Movement Disorders
Phase I
Meteorin
Nervous System Diseases / Neuropathic pain and Huntington's disease
Pre-clinical
NSD726
Aniona
Nervous System Diseases / Neurogenic Inflammation
Pre-clinical
NSD801
Aniona
Nervous System Diseases / Ataxia
Pre-clinical
NsG0301
Nervous System Diseases / Parkinson Disease
Pre-clinical
TransCon Hydrogel Pramipexole
Ascendis Pharma A/S
Nervous System Diseases / Parkinson Disease
Pre-clinical
Balaglitazone
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2
Phase III
Liraglutide
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2
Phase III
Lixisenatide, Lyxumia®
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2
Phase III
Tesofensine
Nutritional and Metabolic Diseases / Obesity
Phase III
LCP-AtorFen
Veloxis Pharmaceuticals A/S
Nutritional and Metabolic Diseases / Dyslipidemias
Phase II
LixiLan
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2
Phase II
Semaglutide
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2